Browsing Tag
Marc de Garidel
3 posts
Valerio Therapeutics and Abivax target next-generation therapies for inflammatory disease
Valerio may gain cash and platform validation from Abivax, but definitive terms and preclinical delivery will decide whether the alliance creates value.
AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn
AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an…
Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics
Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from…